Skip to main content

Part of the book series: Developments in Nuclear Medicine ((DNUM,volume 16))

Abstract

In order to visualise uptake of a radiopharmaceutical in a particular organ or tissue, the target organ must contain an adequate amount of tracer, and the surroundings must be as free as possible from activity. The latter can include radioactivity circulating in the blood, background activity, and adjacent activity in organs or sites unrelated to the object to be visualised.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Kluwer Academic Publishers

About this chapter

Cite this chapter

De Schrijver, M. (1989). Characteristics of the Alternative Radiopharmaceutical. In: Scintigraphy of Inflammation with Nanometer-sized Colloidal Tracers. Developments in Nuclear Medicine, vol 16. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-2385-0_5

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-2385-0_5

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-7574-9

  • Online ISBN: 978-94-009-2385-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics